Fidelity Investments’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9
| Closed | -$114 | – | 5753 |
|
|
2024
Q1 | $114 | Buy |
+9
| New | +$131 | ﹤0.01% | 4964 |
|
|
2023
Q3 | – | Sell |
-1
| Closed | -$13 | – | 5663 |
|
|
2023
Q2 | $13 | Buy |
+1
| New | +$12 | ﹤0.01% | 5250 |
|
|
2020
Q3 | – | Sell |
-5,264
| Closed | -$464K | – | 4105 |
|
|
2020
Q2 | $464K | Sell |
5,264
-37,999
| -88% | -$4.02M | ﹤0.01% | 2522 |
|
|
2020
Q1 | $4.84M | Sell |
43,263
-9,863
| -19% | -$1.94M | ﹤0.01% | 1948 |
|
|
2019
Q4 | $13M | Sell |
53,126
-6,277
| -11% | -$1.58M | ﹤0.01% | 1751 |
|
|
2019
Q3 | $20.5M | Buy |
59,403
+135
| +0.2% | +$73.4K | ﹤0.01% | 1561 |
|
|
2019
Q2 | $54.6M | Buy |
59,268
+583
| +1% | +$716K | 0.01% | 1176 |
|
|
2019
Q1 | $93.6M | Buy |
58,685
+444
| +0.8% | +$800K | 0.01% | 939 |
|
|
2018
Q4 | $109M | Buy |
58,241
+643
| +1% | +$1.4M | 0.01% | 812 |
|
|
2018
Q3 | $136M | Buy |
57,598
+6,035
| +12% | +$18.7M | 0.02% | 814 |
|
|
2018
Q2 | $178M | Buy |
51,563
+141
| +0.3% | +$432K | 0.02% | 713 |
|
|
2018
Q1 | $146M | Buy |
51,422
+2,795
| +6% | +$8.37M | 0.02% | 820 |
|
|
2017
Q4 | $125M | Sell |
48,627
-9,686
| -17% | -$27.5M | 0.01% | 893 |
|
|
2017
Q3 | $165M | Sell |
58,313
-11
| -0% | -$29K | 0.02% | 758 |
|
|
2017
Q2 | $138M | Buy |
58,324
+2,907
| +5% | +$5.76M | 0.02% | 825 |
|
|
2017
Q1 | $140M | Sell |
55,417
-2,225
| -4% | -$6.4M | 0.02% | 851 |
|
|
2016
Q4 | $130M | Sell |
57,642
-33
| -0.1% | -$78.5K | 0.02% | 856 |
|
|
2016
Q3 | $145M | Buy |
57,675
+192
| +0.3% | +$573K | 0.02% | 815 |
|
|
2016
Q2 | $176M | Buy |
57,483
+7,215
| +14% | +$23.5M | 0.02% | 720 |
|
|
2016
Q1 | $160M | Sell |
50,268
-3,676
| -7% | -$15.3M | 0.02% | 760 |
|
|
2015
Q4 | $277M | Buy |
53,944
+386
| +0.7% | +$1.69M | 0.04% | 518 |
|
|
2015
Q3 | $170M | Buy |
53,558
+69
| +0.1% | +$268K | 0.02% | 710 |
|
|
2015
Q2 | $214M | Buy |
53,489
+270
| +0.5% | +$1.04M | 0.03% | 662 |
|
|
2015
Q1 | $213M | Buy |
53,219
+1,916
| +4% | +$8.78M | 0.03% | 665 |
|
|
2014
Q4 | $252M | Buy |
51,303
+607
| +1% | +$2.6M | 0.03% | 578 |
|
|
2014
Q3 | $206M | Buy |
50,696
+11,244
| +29% | +$42.2M | 0.03% | 650 |
|
|
2014
Q2 | $160M | Buy |
39,452
+3,766
| +11% | +$15.4M | 0.02% | 765 |
|
|
2014
Q1 | $162M | Buy |
35,686
+5,499
| +18% | +$22.2M | 0.02% | 735 |
|
|
2013
Q4 | $106M | Sell |
30,187
-16,943
| -36% | -$66.1M | 0.01% | 950 |
|
|
2013
Q3 | $194M | Sell |
47,130
-2,748
| -6% | -$11.8M | 0.03% | 629 |
|
|
2013
Q2 | $197M | Buy |
+49,878
| New | +$205M | 0.03% | 591 |
|
Other funds holding ACOR
Fidelity Investments's ACOR Position: Q2 2024 in Review
Fidelity Investments sold out of Acorda Therapeutics (ACOR) in Q2 2024, closing a stake of 9 shares — an estimated $114 sold.
Fidelity Investments first reported a position in ACOR in Q2 2013 and held it in 31 quarters. The position peaked at $277M in Q4 2015. 2 funds tracked by Wall St. Rank hold ACOR as of Q2 2024.
- Fidelity Investments reported no remaining Acorda Therapeutics position as of Q2 2024 after selling out during the quarter.
- Fidelity Investments sold 9 Acorda Therapeutics shares in Q2 2024, an estimated $114.
- Fidelity Investments first reported a position in Acorda Therapeutics in Q2 2013 and held it in 31 quarters.
- Fidelity Investments's Acorda Therapeutics position peaked at $277M in Q4 2015.
- 2 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2024.
Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.